Reduced Fitness Costs of <italic toggle="yes">mcr-1.2</italic> Compared to Mutated <italic toggle="yes">pmrB</italic> in Isogenic Colistin-Resistant KPC-3-Producing <named-content content-type="genus-species">Klebsiella pneumoniae</named-content>

ABSTRACT In the present study, we provide the results of a detailed genomic analysis and the growth characteristics of a colistin-resistant KPC-3-producing Klebsiella pneumoniae sequence type 512 (ST512) isolate (the colR-KPC3-KP isolate) with a mutated pmrB and isogenic isolates of colR-KPC3-KP wit...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cesira Giordano, Adrian Klak, Simona Barnini, Monika A. Chlebowicz, Mariacristina Menconi, John W. Rossen, Alexander W. Friedrich, Erik Bathoorn
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2019
Materias:
Acceso en línea:https://doaj.org/article/4b7162f14b10463f9b0c1b72fb88e820
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4b7162f14b10463f9b0c1b72fb88e820
record_format dspace
spelling oai:doaj.org-article:4b7162f14b10463f9b0c1b72fb88e8202021-11-15T15:22:24ZReduced Fitness Costs of <italic toggle="yes">mcr-1.2</italic> Compared to Mutated <italic toggle="yes">pmrB</italic> in Isogenic Colistin-Resistant KPC-3-Producing <named-content content-type="genus-species">Klebsiella pneumoniae</named-content>10.1128/mSphere.00551-192379-5042https://doaj.org/article/4b7162f14b10463f9b0c1b72fb88e8202019-12-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mSphere.00551-19https://doaj.org/toc/2379-5042ABSTRACT In the present study, we provide the results of a detailed genomic analysis and the growth characteristics of a colistin-resistant KPC-3-producing Klebsiella pneumoniae sequence type 512 (ST512) isolate (the colR-KPC3-KP isolate) with a mutated pmrB and isogenic isolates of colR-KPC3-KP with mcr-1.2 isolated from an immunocompromised patient. From 2014 to 2017, four colR-KPC3-KP isolates were detected in rectal swab samples collected from a pediatric hematology patient at the Azienda Ospedaliero-Universitaria Pisana in Pisa, Italy. Whole-genome sequencing was performed by MiSeq sequencing (Illumina). Growth experiments were performed using different concentrations of colistin. The growth lag phases both of an isolate harboring a deletion in pmrB and of clonal variants with mcr-1.2 were assessed by the use of real-time light-scattering measurements. In the first isolate (isolate 1000-pmrBΔ, recovered in September 2014), a 17-nucleotide deletion in pmrB was detected. In subsequent isolates, the mcr-1.2 gene associated with the plasmid pIncX4-AOUP was found, while pmrB was intact. Additionally, plasmid pIncQ-AOUP, harboring aminoglycoside resistance genes, was detected. The growth curves of the first three isolates were identical without colistin exposure; however, at higher concentrations of colistin, the growth curves of the isolate with a deletion in pmrB showed longer lag phases. We observed the replacement of mutated colR-KPC3-KP pmrB by isogenic isolates with multiple resistance plasmids, including mcr-1.2-carrying pIncX4, probably due to coselection under gentamicin treatment in a patient with prolonged colR-KPC3-KP carriage. The carriage of these isolates persisted in follow-up cultures. Coselection and the advantages in growth characteristics suggest that the plasmid-mediated resistance conferred by mcr has fewer fitness costs in colR-KPC3-KP than mutations in chromosomal pmrB, contributing to the success of this highly resistant hospital-adapted epidemiological lineage. IMPORTANCE Our study shows a successful prolonged human colonization by a colistin-resistant Klebsiella pneumoniae isolate harboring mcr-1.2. An intense antibiotic therapy contributed to the maintenance of this microorganism through the acquisition of new resistance genes. The isolates carrying mcr-1.2 showed fewer fitness costs than isogenic isolates with a pmrB mutation in the chromosome. Coselection and reduced fitness costs may explain the replacement of isolates with the pmrB mutation by other isolates and the ability of the microorganism to persist despite antibiotic treatment.Cesira GiordanoAdrian KlakSimona BarniniMonika A. ChlebowiczMariacristina MenconiJohn W. RossenAlexander W. FriedrichErik BathoornAmerican Society for Microbiologyarticlecolistinfitness costmcr-1.2molecular epidemiologyMicrobiologyQR1-502ENmSphere, Vol 4, Iss 6 (2019)
institution DOAJ
collection DOAJ
language EN
topic colistin
fitness cost
mcr-1.2
molecular epidemiology
Microbiology
QR1-502
spellingShingle colistin
fitness cost
mcr-1.2
molecular epidemiology
Microbiology
QR1-502
Cesira Giordano
Adrian Klak
Simona Barnini
Monika A. Chlebowicz
Mariacristina Menconi
John W. Rossen
Alexander W. Friedrich
Erik Bathoorn
Reduced Fitness Costs of <italic toggle="yes">mcr-1.2</italic> Compared to Mutated <italic toggle="yes">pmrB</italic> in Isogenic Colistin-Resistant KPC-3-Producing <named-content content-type="genus-species">Klebsiella pneumoniae</named-content>
description ABSTRACT In the present study, we provide the results of a detailed genomic analysis and the growth characteristics of a colistin-resistant KPC-3-producing Klebsiella pneumoniae sequence type 512 (ST512) isolate (the colR-KPC3-KP isolate) with a mutated pmrB and isogenic isolates of colR-KPC3-KP with mcr-1.2 isolated from an immunocompromised patient. From 2014 to 2017, four colR-KPC3-KP isolates were detected in rectal swab samples collected from a pediatric hematology patient at the Azienda Ospedaliero-Universitaria Pisana in Pisa, Italy. Whole-genome sequencing was performed by MiSeq sequencing (Illumina). Growth experiments were performed using different concentrations of colistin. The growth lag phases both of an isolate harboring a deletion in pmrB and of clonal variants with mcr-1.2 were assessed by the use of real-time light-scattering measurements. In the first isolate (isolate 1000-pmrBΔ, recovered in September 2014), a 17-nucleotide deletion in pmrB was detected. In subsequent isolates, the mcr-1.2 gene associated with the plasmid pIncX4-AOUP was found, while pmrB was intact. Additionally, plasmid pIncQ-AOUP, harboring aminoglycoside resistance genes, was detected. The growth curves of the first three isolates were identical without colistin exposure; however, at higher concentrations of colistin, the growth curves of the isolate with a deletion in pmrB showed longer lag phases. We observed the replacement of mutated colR-KPC3-KP pmrB by isogenic isolates with multiple resistance plasmids, including mcr-1.2-carrying pIncX4, probably due to coselection under gentamicin treatment in a patient with prolonged colR-KPC3-KP carriage. The carriage of these isolates persisted in follow-up cultures. Coselection and the advantages in growth characteristics suggest that the plasmid-mediated resistance conferred by mcr has fewer fitness costs in colR-KPC3-KP than mutations in chromosomal pmrB, contributing to the success of this highly resistant hospital-adapted epidemiological lineage. IMPORTANCE Our study shows a successful prolonged human colonization by a colistin-resistant Klebsiella pneumoniae isolate harboring mcr-1.2. An intense antibiotic therapy contributed to the maintenance of this microorganism through the acquisition of new resistance genes. The isolates carrying mcr-1.2 showed fewer fitness costs than isogenic isolates with a pmrB mutation in the chromosome. Coselection and reduced fitness costs may explain the replacement of isolates with the pmrB mutation by other isolates and the ability of the microorganism to persist despite antibiotic treatment.
format article
author Cesira Giordano
Adrian Klak
Simona Barnini
Monika A. Chlebowicz
Mariacristina Menconi
John W. Rossen
Alexander W. Friedrich
Erik Bathoorn
author_facet Cesira Giordano
Adrian Klak
Simona Barnini
Monika A. Chlebowicz
Mariacristina Menconi
John W. Rossen
Alexander W. Friedrich
Erik Bathoorn
author_sort Cesira Giordano
title Reduced Fitness Costs of <italic toggle="yes">mcr-1.2</italic> Compared to Mutated <italic toggle="yes">pmrB</italic> in Isogenic Colistin-Resistant KPC-3-Producing <named-content content-type="genus-species">Klebsiella pneumoniae</named-content>
title_short Reduced Fitness Costs of <italic toggle="yes">mcr-1.2</italic> Compared to Mutated <italic toggle="yes">pmrB</italic> in Isogenic Colistin-Resistant KPC-3-Producing <named-content content-type="genus-species">Klebsiella pneumoniae</named-content>
title_full Reduced Fitness Costs of <italic toggle="yes">mcr-1.2</italic> Compared to Mutated <italic toggle="yes">pmrB</italic> in Isogenic Colistin-Resistant KPC-3-Producing <named-content content-type="genus-species">Klebsiella pneumoniae</named-content>
title_fullStr Reduced Fitness Costs of <italic toggle="yes">mcr-1.2</italic> Compared to Mutated <italic toggle="yes">pmrB</italic> in Isogenic Colistin-Resistant KPC-3-Producing <named-content content-type="genus-species">Klebsiella pneumoniae</named-content>
title_full_unstemmed Reduced Fitness Costs of <italic toggle="yes">mcr-1.2</italic> Compared to Mutated <italic toggle="yes">pmrB</italic> in Isogenic Colistin-Resistant KPC-3-Producing <named-content content-type="genus-species">Klebsiella pneumoniae</named-content>
title_sort reduced fitness costs of <italic toggle="yes">mcr-1.2</italic> compared to mutated <italic toggle="yes">pmrb</italic> in isogenic colistin-resistant kpc-3-producing <named-content content-type="genus-species">klebsiella pneumoniae</named-content>
publisher American Society for Microbiology
publishDate 2019
url https://doaj.org/article/4b7162f14b10463f9b0c1b72fb88e820
work_keys_str_mv AT cesiragiordano reducedfitnesscostsofitalictoggleyesmcr12italiccomparedtomutateditalictoggleyespmrbitalicinisogeniccolistinresistantkpc3producingnamedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontent
AT adrianklak reducedfitnesscostsofitalictoggleyesmcr12italiccomparedtomutateditalictoggleyespmrbitalicinisogeniccolistinresistantkpc3producingnamedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontent
AT simonabarnini reducedfitnesscostsofitalictoggleyesmcr12italiccomparedtomutateditalictoggleyespmrbitalicinisogeniccolistinresistantkpc3producingnamedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontent
AT monikaachlebowicz reducedfitnesscostsofitalictoggleyesmcr12italiccomparedtomutateditalictoggleyespmrbitalicinisogeniccolistinresistantkpc3producingnamedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontent
AT mariacristinamenconi reducedfitnesscostsofitalictoggleyesmcr12italiccomparedtomutateditalictoggleyespmrbitalicinisogeniccolistinresistantkpc3producingnamedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontent
AT johnwrossen reducedfitnesscostsofitalictoggleyesmcr12italiccomparedtomutateditalictoggleyespmrbitalicinisogeniccolistinresistantkpc3producingnamedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontent
AT alexanderwfriedrich reducedfitnesscostsofitalictoggleyesmcr12italiccomparedtomutateditalictoggleyespmrbitalicinisogeniccolistinresistantkpc3producingnamedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontent
AT erikbathoorn reducedfitnesscostsofitalictoggleyesmcr12italiccomparedtomutateditalictoggleyespmrbitalicinisogeniccolistinresistantkpc3producingnamedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontent
_version_ 1718428006286884864